↓ Skip to main content

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

Overview of attention for article published in Acta Neuropathologica, May 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 2,606)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
12528 Dimensions

Readers on

mendeley
8801 Mendeley
Title
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Published in
Acta Neuropathologica, May 2016
DOI 10.1007/s00401-016-1545-1
Pubmed ID
Authors

David N. Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K. Cavenee, Hiroko Ohgaki, Otmar D. Wiestler, Paul Kleihues, David W. Ellison

Abstract

The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor. For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era. As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA fusion-positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered. The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance. Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded. Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.

X Demographics

X Demographics

The data shown below were collected from the profiles of 166 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8,801 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 9 <1%
United Kingdom 7 <1%
Japan 4 <1%
Brazil 4 <1%
Italy 3 <1%
France 3 <1%
Spain 3 <1%
Czechia 3 <1%
Netherlands 2 <1%
Other 17 <1%
Unknown 8746 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1133 13%
Student > Master 1000 11%
Student > Ph. D. Student 967 11%
Researcher 866 10%
Student > Doctoral Student 639 7%
Other 1691 19%
Unknown 2505 28%
Readers by discipline Count As %
Medicine and Dentistry 2498 28%
Biochemistry, Genetics and Molecular Biology 1082 12%
Neuroscience 630 7%
Agricultural and Biological Sciences 449 5%
Engineering 209 2%
Other 1109 13%
Unknown 2824 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 686. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2023.
All research outputs
#31,007
of 25,837,817 outputs
Outputs from Acta Neuropathologica
#8
of 2,606 outputs
Outputs of similar age
#563
of 317,587 outputs
Outputs of similar age from Acta Neuropathologica
#1
of 27 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,606 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,587 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.